MedEvidence! Truth Behind the Data

Send us a textDr. Michael Koren joins Kevin Geddings to discuss how Knowledge is Power - especially when it comes to medicine. The doctor explains how diagnostic tests like high sensitivity C-reactive protein (HSCRP) empower physicians and patients by giving insight into heart attack and stroke risk. Dr. Koren also tells us that even simple things like knowing you are in a research study can improve patient outcomes, and that knowledge is the guiding principle in medicine.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textDr. Michael Koren joins Kevin Geddings to discuss why atrial fibrillation (AFib) receives so much attention in advertising compared to other services hospitals provide. The cardiologist explains the financial incentives for hospitals and device manufacturers behind these marketing campaigns, contrasting them with clinical research, which has the financial and legal incentive to measure accurate data when evaluating the success rate of a particular medication or device. Dr. Koren also discusses a current research study for a new AFib monitoring patch to highlight the difference between objective medical research and profit-driven medical marketing.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textDr. Michael Bernhardt, a dermatologist and clinical researcher, joins Dr. Erich Schramm to discuss the revolutionary advancements in psoriasis treatment over the past two decades. The doctors discuss how psoriasis is an inflammatory disease more than an autoimmune disease. They discuss what inflammation is, the inflammation pathway in the body, and how different medications can help suppress the body's out-of-control inflammatory response. They go over the history of psoriasis medications, which ones may be appropriate for different severities of the disease, and what's on the cutting edge of psoriasis treatment.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textDoctor Carolyn Tran joins Neurologist Steven Toenjes to discuss migraines. Migraine is a complex brain disease affecting one in five women and one in ten men, with treatments ranging from traditional medications to cutting-edge therapies targeting specific pathways in the brain. The doctors talk about the causes - or lack thereof, the lack of treatment, and common misconceptions about what headaches should be classified as migraines. Dr. Toenjes explains the phases of migraine, including prodrome, aura, pain, and postdrome. Then the two doctors explore many treatment options, discussing the uses, benefits, and drawbacks of each class of treatment.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textThe FDA has granted full approval to Novavax's COVID-19 vaccine, providing an alternative to mRNA vaccines that works through a different mechanism using proteins and adjuvants. Despite being four years into the pandemic, COVID-19 remains a significant health concern, causing approximately 1 in 200 deaths in the US in 2025.• Novavax uses bioengineered spike proteins combined with an adjuvant rather than mRNA technology• FDA approved Novavax for all Americans over 65 and those 12-64 with at least one risk factor• Risk factors include conditions like asthma, diabetes, and obesity• Northeast Florida contributed 500 patients to the original Novavax clinical trials• Encore Research Group is currently enrolling participants for an oral COVID vaccine clinical trial• Participants in the oral vaccine trial will receive compensation for their timeFor more information about participating in the oral COVID vaccine study, visit EncoreDocs.com or call 904-730-0101.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textDr. Michael Koren shares exciting news about the revival of an oral COVID vaccine study previously halted by government spending cuts. The non-mRNA vaccine trial represents an important alternative approach that apparently received priority status even under strict budget reviews.• Oral COVID vaccine study in Jacksonville now actively enrolling participants after being temporarily halted by DOGE initiative• Study offers a non-mRNA alternative that might appeal to those concerned about messenger RNA technology• Summer months in Florida paradoxically see increases in respiratory infections as people spend more time indoors with air conditioning• Dr. Koren explains why most vaccines require injection rather than oral delivery• Discussion of pharmaceutical pricing disparities between US and other countries• The "innovation premium" Americans pay funds research that benefits the global population• Finding balance between incentivizing medical breakthroughs and ensuring fair cost distribution remains challengingFor reliable, unbiased medical information, visit MedEvidence.com. To learn more about participating in the oral COVID vaccine study or other clinical trials, visit EncoreDocs.com.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textUrologist and president of the Duval County Medical Society Dr. Ali Kasraeian joins Dr. Michael Koren to update us on recent advances in Urology. In Part 3 of this series, Dr. Koren and Dr. Kasraeian dive deep into the latest advancements in prostate cancer detection and treatment options. They explore the evolution from basic PSA screening to personalized approaches . Dr. Kasraeian focuses on the modern shift to patient-focused, individualized approaches that meet patients where they are by balancing early detection with quality of life considerations.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textDr. Michael Koren shares insights from his recent speaking tour across Saudi Arabia where he delivered 14 lectures in 6 days to sophisticated healthcare providers eager for American medical research. His observations reveal surprising aspects of Saudi healthcare including English as the professional language, universal insurance coverage, and the powerful roles women play despite traditional cultural restrictions.• Saudi Arabia offers universal healthcare coverage with additional private insurance options• English serves as the professional language in Saudi healthcare settings• Women in healthcare occupy positions of authority despite only gaining driving rights in 2019• Female healthcare professionals maintain strong professional presence while following traditional covering practices• Dr. Koren shared research on improving cholesterol management published in JACC• Saudi physicians highly value clinical research conducted in Northeast Florida• The rivalry between Saudi Arabia and Iran remains strong despite geographic proximity• MedEvidence platform received enthusiastic response from Saudi healthcare professionalsVisit MedEvidence.com to learn how we break down complex medical issues, identify knowledge gaps, and explain the research process for both healthcare professionals and patients.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textUrologist and president of the Duval County Medical Society Dr. Ali Kasraeian joins Dr. Michael Koren to update us on recent advances in Urology. In Part 2 of this series, Dr. Koren and Dr. Kasraeian explore into the controversial history of PSA testing. Dr. Kasraeian explains how this simple blood test revolutionized prostate cancer detection while creating challenges around overdiagnosis and overtreatment. The doctors also talk about how modern approaches to prostate screening have evolved to balance finding dangerous cancers while avoiding unnecessary interventions.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textUrologist and president of the Duval County Medical Society Dr. Ali Kasraeian joins Dr. Michael Koren to update us on recent advances in Urology. In Part 1 of this series, Dr. Kasraeian talks about his journey, from growing up in a medical family to becoming a urologist and healthcare advocate with a passion for innovative approaches to prostate cancer treatment. Part 1 highlights how mentorship, family influence, and opportunities in healthcare policy shaped his career path and commitment to physician leadership.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textDr. Michael Koren sits down with Dr. Murali Ramaswamy to explore the concept of Research as a Care Option. They compare this with the misconception of research as a treatment option to reveal how clinical trials provide structured environments that often lead to better health outcomes regardless of the specific intervention. They debunk the idea that clinical trials provide treatment, due to the randomized nature of trials, but discuss the numerous health benefits seen by patients who enter a clinical trial - even those who get a placebo!Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textDr. Michael Koren joins Kevin Geddings to discuss how tariffs could significantly impact pharmaceutical prices. They talk about how barriers to import may affect both prescription and especially over-the-counter medication prices. They move onto the difficulty of starting new drug manufacturing in the US and how clinical trials may provide relief for some patients.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textOn this episode, recorded in front of a live audience, Cardiologist Dr. Michael Koren is joined by pulmonologist Dr. Mitchell Rothstein to discuss Chronic Obstructive Pulmonary Disease (COPD). COPD is obstruction of the lungs, making it hard to breathe and represents a significant health challenge . It affects millions of Americans and is a leading cause of mortality, yet receives disproportionately low research funding compared to conditions with fewer annual deaths. The doctors explore this chronic lung condition from its biological mechanisms to the latest treatment approaches, highlighting the critical need for increased awareness and research investment.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textDr. Michael Koren Join Kevin Geddings to reflect on the evolution of medical research ethics from the troubling practices at Willowbrook Hospital in the 1970s to today's patient-centered approach. He connects this progression to John Lennon and Yoko Ono's final major concert, which raised awareness about conditions at the hospital while highlighting how far ethics in clinical trials have advanced.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textDr. Michael Koren shares insights from his presentation at the American College of Cardiology meeting in Chicago about a groundbreaking oral PCSK9 inhibitor that could lower cholesterol by 80% when combined with a statin. The development represents a significant advancement in treatment options for the 20% of patients who don't respond adequately to statins alone or experience statin intolerance. They also chat about Chicago and the importance of things in moderation.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textPsychiatrist Dr. Rachna Saralka joins Cardiologist Dr. Michael Koren to explore the emerging field of artificial intelligence in psychology. They discuss the promise and shortfalls of using AI in this field, and the need for hard data  and validated results through clinical trials. They get into empathy, the placebo effect, and potential use of AI to train psychologists and other doctors just like chess bots can help teach people to play chess.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textOn this Monday Morning Minute, Dr. Michael Koren draws parallels between the NCAA Final Four basketball tournament and the clinical research process. He explains that in medicine, researchers start with literally 10,000 potential molecules, which get whittled down to only three or four medications to be tested in big, phase III clinical trials. This ensures that only the most promising medical technologies get approved, just like the most promising teams get to the National Championships.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textJudith Abbey, DNP, shares her journey from medical student in Ghana to healthcare entrepreneur in Florida, where she founded On the Go Drip, a mobile IV therapy service delivering treatments directly to patients' homes. Dr. Michael Koren asks her about her history and business, and the two of them dive into some of the controversy surrounding supplement treatments.Helpful Links:On The Go DripResearch Methods class at University of North FloridaThe Book Clinical Decision AnalysisBe a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textCardiologist Dr. Michael Koren joins Kevin Geddings to discuss progress in the world of cholesterol management. Dr. Koren explains the importance of getting cholesterol - especially LDL cholesterol - under control and the potential benefits to heart attack and stroke risk. They discuss some of the problems with current therapies; they are highly effective but can introduce burdens to patients with the back-and-forth for multiple medications. Dr. Koren then reveals new medicatiosn being studied which may combine multiple cholesterol medications into a single pill, reducing barriers and  potentially improving outcomes.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textOn This week's episode, Dr. Michael Koren Interviews local media entrepreneur Randall Thomas, host of PB and Jax. They discuss how “The Internet is a Weird Place.” They examine the algorithms, platforms, and biases that make up our experience on the internet. Mr. Thomas explains how the algorithms determine what gains traction and that all a creator can do is hope to increase their chances of something going viral. They wrap the discussion up by looking at how this race for clicks might affect medical information on the internet. Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textKen Amaro, a former broadcaster with 42 years of experience and current Jacksonville City Councilman for District 1, joins Eric Ross, RN. Ken shares his decade-long journey with Type 2 diabetes from diagnosis through management and lifestyle adaptations, dropping motivational nuggets and tips he's learned along the way. The two discuss the need for regular checkups, the importance of listening to your body, and the importance of watching what you eat.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textOn this week's Monday Morning Minute, Dr. Michael Koren joins Kevin Geddings to answer the question "can I participate in clinical trials even if I'm not sick?" They discuss how having "healthy participants" is critical for some clinical trials. They look at a current study that examines how the body processes oral statin medications and if those with kidney disease process medicine in a different way than those with healthy livers.Koren's Key Takeaways:People without disease can be essential to the clinical trial processStatins are still effective, even if pharmaceutical marketing has slowedJoining a clinical trial as a low-risk "health participant" is a great way to learn about the processBe a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textIn this episode, Dr. Michael Koren is joined by Dr. Sunil Joshi, the Chief Health Officer of the city of Jacksonville, Florida. Dr. Joshi runs through five health initiatives to lower the premature death rate in the city and county. The doctors discuss health inequalities, the social and economic factors that contribute to negative health outcomes, and the pioneering efforts of the city's Chief Health Officer.Dr. Joshi introduces us to:Jacksonville's Health Priorities (jacksonville.gov/mayor/mayors-priorities/health)HealthLink Jax (jacksonville.gov/healthlinkjax): Free virtual healthcare servicesJaxCareConnect (jaxcareconnect.org): Free and charitable clinicals in JacksonvilleElderSource (myeldersource.org): Providing food assistance for elderly Jacksonville residents988 (dial 9-8-8): Mental health crisis hotlineGet Covered Jax (jacksonville.gov/getcoveredjax): Free assistance finding Marketplace healthcare insuranceNortheast Florida Healthy Start Coalition (nefhealthystart.org): Services to reduce infant mortalityBe a part of advancing science by participating in clinical research.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textThis week Dr. Koren Joins Kevin Geddings for the Monday Morning Minute to talk about a clinical research procedure to resurface a part of the digestive system that contributes to obesity and diabetes. This program is currently being studied in northeast Florida. Dr. Koren explains how the device works, it's expected results, and how you can learn more and potentially join this area of study.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textDr. Trevor Greene joins Dr. Michael Koren to discuss the effects of inflammation on the cardiovascular system. The two cardiologists talk about biomarkers that have increasing importance: including liporprotein(a) and hsCRP. The doctors finish up with actionable lifestyle changes everyone can implement. Koren's Key Takeaways:Inflammation plays a big role in the bodyChronic inflammation influences cardiovascular diseaseThe predictive value of hsCRP is being investigated nowBe a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textMost pills are taken daily, and many vaccines protect for around a year, but could medical device products last even longer? In this episode of the Monday Morning Minute, Dr. Michael Koren joins Kevin Geddings and explains what medical devices are and how they can make long-term differences for patients. The two discuss device treatments for diabetes, weight loss, atrial fibrillation, blood pressure, and how AI may be able to help.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on AppleWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramTwitterLinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textAnesthesiologist Dr. Todd Bertoch speaks with Dr. Michael Koren in this exciting episode about the a new pain medication, Journavx (suzetrigine), which was just approved by the FDA in January, 2025. The doctors discuss this breakthrough pain management medication, its safety profile, side effects, and how it compares to NSAIDs, acetaminophen, and opioids. They also dive into the approval process, how trials were conducted and standardized, and where the medication will go from here.Koren's Key Takeaways:New options like suzetrigine for pain medication that are non-addicting are neededThis medication is another tool, not a replacement for opioidsThe clinical trials for this medication have been rigorousBe a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on AppleWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramTwitterLinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textKevin Geddings talks with Cardiologist Dr. Michael Koren about the health risks and benefits of alcohol, which continue to be significant topics of discussion in health circles. This episode delves into a late Biden-era proposal for alcohol warning labels amid growing concerns about cancer risks associated with consumption. Dr. Koren expresses a desire for more clinical trial data on this subject looking at the health benefits and risks of alcohol consumption.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on AppleWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramTwitterLinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textRheumatologist Dr. Manish Jain joins Cardiologist Dr. Michael Koren as they discuss how performing clinical trials can help physicians become more holistic and knowledgeable, and how the process can result in better care for patients. In this conversation, the principal investigators explore Dr. Manish's journey as a clinician and investigator, including how he learned to approach patients about research, understanding their motivations, and the importance of education in bridging clinical practice with research.Sign up at investigatortraining.info to join MedEvidence! on May 4th and 5th for Clinical Research Training for Physicians. Designed for medical professionals, this comprehensive course covers essential skills for conducting clinical research, industry-specific terminology, and effective tactics for successful trials. Upon course completion, the physician will have met the criteria for GCP (Good Clinical Practice) training requirements and be able to confidently incorporate clinical research into their daily practice.This course is suited for Physicians, Physician Assistants, Nurses (including NPs), Pharmacists, Pharmacy Technicians, Dentists, Allied Dental Professionals, Registered Dietitians, Registered Dietitian Technicians, Psychologists, and Social Workers.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on AppleWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramTwitterLinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textDr. Dan Schlager, an ER physician, joins Dr. Michael Koren to talk about his life path as a physician inventor who transformed emergency response through an innovative GPS technology. Dr. Schlager also talks about other inventions like a lightning-proof shirt, and the legal and bureaucratic process of getting and defending patents from those who would circumvent them. All of this underpins the vital importance of innovation in medicine.Koren's Key Takeaways:Innovation and invention moves medicine forwardWe stand on the shoulders of giantsThe definition of a toll is in the eye of the beholderBe a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on AppleWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramTwitterLinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textDr. Michael Koren joins Kevin Geddings as they explore the history and significance of clinical trial integrity over the last 50 years. Dr. Koren brings up the story of Dr. David Baltimore, who's test results on viruses were questioned and who's vigilance helped establish the rigorous standards we see today. It highlights the importance of reliable research practices and tools like MedEvidence in empowering individuals to make informed health decisions.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on AppleWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramTwitterLinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textOn this episode, medicare and insurance with expert Andy Stansfield joins Dr. Michael Koren to review the differences between traditional Medicare and Medicare Advantage. They also dive provide insight into navigating the system effectively and address common frustrations faced by patients and what you can do when insurance denies a claim.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on AppleWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramTwitterLinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textIn this episode, Obesity, Lifestyle, and Pediatric Specialist Dr. Randolph Nunez joins Cardiologist and Clinical Researcher Dr. Michael Koren as they discuss the approaches to managing obesity, particularly in children and adolescents. Dr. Nunez talks about Keystone Habits like sleep, and how tackling those habits are the key to sustained weight loss. The doctors discuss the psychological, physical, and biologic processes that can have an effect on weight and the difficulty of willpower. They also talk about new medications, GLP-1 inhibitors, surgical options, and how these ideas intersect with childhood obesity. They finish by talking about the personalized nature of effective weight management strategies. Koren's Key Takeaways:Willpower varies from person-to-person, day-to-day, and activity-to-activityAn obesity specialist can help fight "food noise," the amount of time a person thinks about eatingA key to weight loss is finding out if there are underlying reasons why a person gained weightBe a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on AppleWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramTwitterLinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textOn this week's MedEvidence Monday Minute, Dr. Michael Koren and Kevin Geddings discuss the superbowl and how the predictions around the outcome - based on past experiences - were no substitute for knowing how the actual game would turn out. They relate this to clinical trials, where a hypothesis can sound sensible and have logical underpinnings, but a randomized, controlled clinical trial is needed to test that hypothesis and see if the outcome matches our predictions.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on AppleWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramTwitterLinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textJoin Pulmonologist Dr. Mitchell Rothstein and Allergist and Immunologist Dr. Steve Dorman as they explore the violent activity that can project particles at 100 miles an hour out of your mouth: coughing! The doctors explain the varied approaches doctors take when trying to find the cause of a cough and what happens inside the body to turn a cough from productive to chronic. They explore things that can stimulate a coughing event and review what medications are currently approved for chronic cough. Finally, the two doctors discuss the possibility of new medications being developed currently in clinical trials. Stay tuned and don't miss this episode.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on AppleWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramTwitterLinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textTechnology like Artificial Intelligence (AI) is being integrated more and more into our lives. It's fast, convenient, and can be used at home to gather more health data than ever. But how do we know if the benefits of these technologies outweigh potential risks and pitfalls? Dr. Mike Hafran joins Dr. Michael Koren to discuss how clinical trials can and have been used to weigh the risks and benefits of new medicines in the past and how clinical trials need to be applied to emerging healthcare technologies (and newly categorized medicines like cannabis) before they are integrated fully into the healthcare system.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on AppleWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramTwitterLinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textThis episode focuses on the FDA's approval of Journavx, a new class of pain medication that offers an alternative to traditional narcotics like OxyContin. Listeners learn about the significance of clinical trials, patient involvement, and the evolution of pain management strategies while emphasizing the need for informed discussions with healthcare providers. • Introduction to Jernovex and its pain management potential • Importance of clinical trials in drug development • Discussion on the practical implications for patients • Shift in medical policy around narcotic use • Overview of phase four trials and their significance • Resources offered by MedEvidence for reliable health information • Call to action for patients to engage with their healthcare providers regarding new treatment optionsBe a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on AppleWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramTwitterLinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textIn this second and final part of this series, Dr. Michael Koren and Dr. Seth Baum discuss the importance of patient retention in cardiovascular clinical trials. They highlight how participants in these trials, even those on placebos, often experience better health outcomes due to increased medical attention. They stress the need for clear communication at the outset, proper participant selection, and continued engagement through education and personal interactions. Dropping out of a trial can negatively impact the study's validity and broader medical advancements. Dr. Koren's Key takeawaysPatient retention is critical for good clinical trial dataMany patients experience medical benefits even when taking a placeboBeyond personal benefits, clinical trials can help millions or billions of peopleRecorded 11/11/2024Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on AppleWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramTwitterLinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textThe trajectory for those with cardiovascular disease has changed drastically in the past few decades. Cardiologists Michael Koren and Seth Baum discuss the amazing 60% drop in cardiovascular mortality since the 1980's and the worrying rebound in heart-related mortality starting around 2012. They dissect various influences for both of these trends, including changes in diet, a widespread drop in medical compliance, and wavering public opinion on heart medicines like statins.Dr. Koren and Dr. Baum then dive into some potential ways to tackle the worrying recent trend, including education and new medicines which may be easier and more effective. They explain how clinical trials are the gold standard for how scientists and researchers gather data about medicine and heart careDr. Koren's Key takeaways:Cardiovascular deaths dropped 60% since 1980, but have risen since 2012There have been recent increases in related conditions like obesity and diabetesFollow doctor recommendations, especially those that relate to your heart!Recorded 11/11/2024Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on AppleWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramTwitterLinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textDr. Michael Koren reflects on his interview with Dr. Anthony Fauci with Kevin Geddings. This episode explores Dr. Fauci's history in public health and his life after exiting the government sphere. Dr. Koren and Kevin Geddings  also highlight the importance of acknowledging uncertainties in science, and how other fields don't always have the same clarity and transparency as medicine. A key takeaway is the MedEvidence! approach: identifying what is known, unknown, and how to learn more. This honest perspective underscores the value of evidence-based medicine, public trust in healthcare, and the critical role of public participation in research trials. .Be sure to also listen to Dr. Koren's interview with Dr. Fauci in our podcast Ep. 260Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on AppleWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramTwitterLinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textJoin Dr. Anthony Fauci and Dr. Michael Koren as they discuss the public health events that have punctuated Dr. Fauci's life. The doctors discuss the difficulties of the HIV epidemic in the 1980's and how Dr. Fauci's early career decision to pursue this emerging threat helped inform and prepare him for the COVID-19 pandemic. Doctors Koren and Fauci wade through the myriad controversies surrounding the public health response to the COVID-19 pandemic; from its origins, the importance of vaccines, and the balance of public health and individual rights. Finally, the two speak about the difficulty of public health communication during an evolving situation and the importance of high-quality data from sources like clinical trials.Koren's Key Takeaways:Scientific integrity and the credible medical information are critical to public healthPrevious healthcare crises can help inform current and future onesBalancing personal rights and public health mandates is a challengeRecorded 1/17/2025Reference:Moreira Jr, Edson D., Nicholas Kitchin, Xia Xu, Samuel S. Dychter, Stephen Lockhart, Alejandra Gurtman, John L. Perez et al. "Safety and efficacy of a third dose of BNT162b2 Covid-19 vaccine." New England journal of medicine 386, no. 20 (2022): 1910-1921. https://www.nejm.org/doi/full/10.1056/NEJMoa2200674COVID update: the AstraZeneca antibody vaccine was just approved overseas. Interested in the next generation of oral COVID vaccine? Contact ENCORE Research group at (904) 760-0166 or visit ENCOREdocs.comBe a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on AppleWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramTwitterLinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textRecent guidelines from the Surgeon General indicate that even moderate alcohol consumption poses significant health risks, particularly increasing the likelihood of several cancers. In this episode, cardiologist Dr. Michael Koren and GI specialist Dr. Bharat Misra analyze the data on alcohol and if it aligns with the Surgeon General's recommendation to add warning labels to alcohol. The doctors suggest limiting the number of days per week alcohol is consumed and challenge traditional views to look at effects on cancers, heart health, and social aspects. They emphasize the need for personal assessment of drinking habits and highlights the importance of having good data and informed conversations with healthcare professionals about individual risks associated with alcohol. Koren's Key Takeaways:Alcohol use is complex and affects many body and social systemsTalking to your doctor is the best way to determine your riskWe could use more high-quality data on alcohol use and its effectsBe a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on AppleWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramTwitterLinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textOn this week's Monday Morning Minute, Dr. Michael Koren and Kevin Geddings discuss the worry uncertainty brings in a changing government landscape and how this affects healthcare. They discuss the stress of not knowing what to expect with competing visions from the incoming administration and how the structure of clinical research trials provides consistency in uncertain times. The two talk about what may change with the second Trump administration, including research funding, healthcare dollars, and access to medicines like the GLP-1 inhibitors Maunjaro and Ozempic that help with diabetes, high blood pressure, and weight loss.Koren's Three Key Takeaways:The new administration's health policies are unclearAccess to GLP-1 inhibitor medications may changeClinical research provides consistent health monitoringRecorded January 20, 2025Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on AppleWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramTwitterLinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textDr. Michael Koren sits down with Alexandria Clark and Anna Fehr of One of a Kind (1-OAK) Clinical Research to discuss their bold decision to launch a clinical research company in 2021, shortly after the disruptions caused by the COVID-19 pandemic. Dr. Koren reflects on how the pandemic reshaped the clinical research landscape, forcing the closure of many smaller sites which couldn't continue seeing patients in-person. Alexandria and Anna saw an opportunity in the vacuum to build a business specializing in high-need areas like asthma, immunology, and gastroenterology. The conversation also explores the unique hurdles of establishing a new clinical research site and the importance of adaptability, planning, community, and instruction for both patients and physicians.Koren's Key Takeaways:The COVID-19 pandemic changed the clinical research landscapeStarting a new clinical research site can be a challenge and must be done with care and tactClinical research sites act as a resource for the community where they are locatedBe a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on AppleWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramTwitterLinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textCardiologist and research scientist with ENCORE Research Group, Dr. Michael Koren highlights the importance of monitoring your key health numbers with Kevin Geddings. The two talk about the importance of checking weight, cholesterol, and blood pressure, emphasizing consistency in measurement practices for accurate tracking. They discuss newer numbers to check for cardiovascular health, including lipoprotein(a) and hsCRP, a marker for vascular inflammation. Both of these metrics are gaining recognition for their role in long-term heart health.Koren's 3 Key Takeaways:Prevention and early detection are critical to long-term healthConsistency is the key to making sure numbers are accurateClinical research is developing new methods of tracking healthBe a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on AppleWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramTwitterLinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textJoin Dr. Koren and Dr. Ridker for part 2, as they examine the effects of silent inflammation on heart health, emphasizing the importance of understanding specific body signals and the biomarker hsCRP. They also discuss the utility of hsCRP testing as a vital marker for predicting cardiovascular risk due to silent inflammation. The doctors explain how inflammation may play a bigger part in heart disease than many patients - and even some doctors - guess.Koren's Key Takeaways:Inflammation plays a critical part in chronic disease, including heart diseaseMedicine is constantly evolving, bridging the gap between research and practicePatients and physicians have to work together to push science forwardBe a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on AppleWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramTwitterLinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textDr. Michael Koren welcomes Dr. Paul Ridker, the leading expert in inflammation and cardiovascular disease, Professor of Medicine at Harvard University, and director of the Center for Cardiovascular Disease Prevention at Brigham and Women's Hospital. Dr. Ridker explains how his career began with challenging traditional medical assumptions, specifically the textbook risk factors for heart attack, and how this manifested in an intense interest in inflammation. The conversation continues into Dr. Ridker's work on groundbreaking research investigating how chronic inflammation drives diseases of aging, including heart attack, stroke, and cancer.The doctors then highlight the pivotal discoveries in inflammation management, particularly the use of statin drugs. Dr. Ridker recounts how statins reduce heart attacks and strokes in individuals with high inflammation markers, regardless of cholesterol levels. These findings revolutionized cardiovascular treatment and emphasized the need to integrate inflammation control into preventive medicine. Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on AppleWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramTwitterLinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textLast week the Surgeon General of the United States, Vivek Murthy, urged congress to pass a law requiring warning labels on alcohol showing the link between even light drinking and gastrointestinal cancers, but is this a good idea? Dr. Michael Korn talks with Kevin Geddings to discuss the balance between the gastrointestinal risks associated with alcohol consumption and its potential cardiovascular benefits while advocating for informed personal choices regarding health. Koren's Top Takeaways• Weigh the relative risks of gastrointestinal and cardiovascular disease• Talk to your doctor about your current situation• Dry January may be a good idea to make sure you aren't addicted to alcoholBe a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on AppleWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramTwitterLinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textThis episode of MedEvidence! features a compelling discussion between cardiologist and medical researcher Dr. Michael Koren and 20th U.S. Surgeon General Dr. Jerome Adams. Dr. Adams shares his unique journey from growing up in rural Maryland to becoming the nation's top doctor, highlighting the role of personal experience in shaping his commitment to public health. The conversation delves into the challenges of navigating evidence-based medicine during crises like COVID-19, the importance of addressing social determinants of health, disease management versus health promotion, and the tension between individual patient care and public health priorities. With insights into policymaking, scientific communication, and trust-building, this episode offers a thoughtful exploration of how evidence shapes decisions in medicine and public health.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on AppleWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramTwitterLinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textUnlock the secrets to successful clinical trials with Dr. Michael Koren and Doug Denham in part 2 of this podcast. The doctors explore participant retention strategies that make a difference to science and to patients. From obesity studies to cholesterol conditions, Drs. Koren and Denham share their experiences  with keeping participants engaged and ensuring trial success. They discuss the importance of personal relationships with patients, maintaining a supportive environment, and the power of setting realistic expectations. The doctors also emphasize the necessity of clear communication, especially during Serious Adverse Events, and the importance maintaining study blindness to prevent bias. The doctors close by discussing the importance of trial volunteers and how the industry can improve communication after a trial is complete.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on AppleWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramTwitterLinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Send us a textDr. Michael Koren and Kevin Geddings discuss New Year's health resolutions and how clinical research can help achieve them. The conversation highlights the ancillary benefits of participating in research, including expert guidance, hands-on care, and reinforced healthy habits. Dr. Koren also explains that exercising regularly, managing cardiovascular health, and quitting smoking are keys to achieving health goals.Recording Date: December 30, 2024Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on AppleWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramTwitterLinkedInWant to learn more checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!